Two new HIV cure cases to be presented in Rio

Two patients, known as Ascent and Kansas City, will be presented as the 12th and 13th cases of HIV cure or prolonged remission after stem cell transplants during an international AIDS conference in Rio de Janeiro.

The information was anticipated by immunologist Christian Gaebler, from Charité Universitätsmedizin Berlin, during a pre-conference. The cases will be detailed in a session dedicated to HIV cure on Wednesday (29).

Gaebler stated that patient Ascent will be number 12 and the one from Kansas City number 13, describing the results as really fascinating. No additional clinical details about the Kansas City patient were revealed.

All 13 cured or in remission patients also had leukemia or another hematological cancer that required the transplant, a high-risk procedure indicated only for fatal diseases. The first recorded case was that of Timothy Ray Brown, the Berlin patient, in 2009.

Researchers are investigating additional mechanisms, such as neutralizing antibodies, that may contribute to virus control without the full CCR5-delta32 mutation.

Makala yanayohusiana

Microscopic view of enhanced natural killer cells attacking cancer cells due to a drug developed by McGill researchers.
Picha iliyoundwa na AI

McGill researchers use reversible drug approach to boost natural killer cells against hard-to-treat cancers

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

Researchers at McGill University report a drug-based method to temporarily enhance natural killer (NK) cells—an immune cell type—by inhibiting two proteins, improving the cells’ ability to attack several aggressive cancers in preclinical experiments.

A small study has found that CAR-T cell therapy may offer a new way to manage HIV over the long term. The approach, already used to treat certain cancers, involves engineering a patient’s own immune cells.

Imeripotiwa na AI

Eight patients with Parkinson's disease have received transplants of dopamine-producing stem cells in a study at Lund University. The first results show promising signs of cell survival without serious side effects.

Researchers in Sweden have created insulin-producing cells from human stem cells that reversed diabetes symptoms when transplanted into mice. The cells matured after placement in the eye and maintained glucose regulation for months. The work was published in Stem Cell Reports.

Imeripotiwa na AI

São Paulo state health authorities have ruled out the second suspected Ebola case in the state this year. The patient, a 31-year-old Brazilian woman who returned from the Democratic Republic of Congo, tested negative.

Jumatano, 22. Mwezi wa saba 2026, 23:27:44

Modeling study suggests earlier drug switches could curb cancer resistance

Jumatatu, 13. Mwezi wa saba 2026, 05:10:33

Cell therapy keeps four children alive years after brain cancer diagnosis

Jumamosi, 4. Mwezi wa saba 2026, 03:47:42

South Africa's BEAT Tuberculosis study improves drug-resistant TB treatment

Jumatatu, 29. Mwezi wa sita 2026, 05:53:04

South Africa begins lenacapavir rollout to cut HIV infections

Jumanne, 23. Mwezi wa sita 2026, 07:27:48

Report shows 98,000 Kenyans unaware they have HIV

Jumamosi, 13. Mwezi wa sita 2026, 22:50:57

Rio Grande do Sul investigates suspected Ebola case

Ijumaa, 29. Mwezi wa tano 2026, 15:41:51

Virus injection halts pancreatic tumor growth in trial

Jumamosi, 16. Mwezi wa tano 2026, 00:33:35

Caribou Biosciences presents car-t updates at healthcare conference

Jumatatu, 11. Mwezi wa tano 2026, 09:49:43

First Spanish hantavirus case confirmed in Madrid hospital quarantine

Alhamisi, 30. Mwezi wa nne 2026, 02:46:42

US Pepfar cuts continue to threaten lenacapavir rollout in South Africa

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa